Biotechnology
Company Overview of PathoGenesis Corporation
Company Overview
PathoGenesis Corporation was acquired by Chiron Corporation on 09/22/2000. PathoGenesis Corporation, a pharmaceutical company, was engaged in the development and commercialization of drugs to treat chronic infectious diseases, as of June 30, 2000.
201 Elliott Avenue West
Seattle, WA 98119
United States
283 Employees
Phone:
206-467-8100
Key Executives for PathoGenesis Corporation
PathoGenesis Corporation does not have any Key Executives recorded.
Similar Private Companies By Industry
| Company Name | Region |
| Senex Biotechnology, Inc. | United States |
| Hemophilia Resources of America, Inc. | United States |
| MPI Research, Inc. | United States |
| Cytomatrix | United States |
| Dartmouth-Hitchcock Clinic | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Efland, NC | Orange County SchoolsPosted: May 22
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact PathoGenesis Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
